<DOC>
	<DOCNO>NCT02668484</DOCNO>
	<brief_summary>There different aortic valve prosthesis use treatment aortic valve disease catheter-based procedure . The current study aim compare two different aortic valve prosthesis regard outcome 30-day 2-year follow-up .</brief_summary>
	<brief_title>REpositionable Versus BallOOn-expandable Prosthesis Trans-catheter Aortic Valve Implantation</brief_title>
	<detailed_description>Important improvement aortic valve prosthesis technology make aim comparable performance prosthesis surgical valve one . The experience early generation aortic valve prosthesis reveal important difference regard incidence paravalvular leakage , need pacemaker valve thrombosis among . Currently new generation valve prosthesis Sapien 3 balloon-expandable valve Lotus , repositionable valve frequently use device . There registry data clinical performance valve type randomize comparison miss .</detailed_description>
	<criteria>1 . Symptomatic aortic valve disease need valve replacement 2 . Heart team ( include least cardiac surgeon interventional cardiologist ) agree eligibility transfemoral TAVI appropriate . 3 . Study patient adult legal consent age . 4 . Study patient provide write informed consent participate study 1 . Life expectancy &lt; 12 month due comorbid condition . 2 . Native aortic valve annulus size morphology suitable Lotus Sapien prosthesis implantation 3 . Preexisting bioprosthetic valve ring aortic valve position . 4 . Preexisting pacemaker ICD/CRT . 5 . Cardiogenic shock hemodynamic instability . 6 . History active endocarditis 7 . Contraindications transfemoral access . 8 . Severe leave ventricular dysfunction LVEF &lt; 30 % . 9 . Severe mitral valve insufficiency . 10 . Echocardiographic evidence intracardiac mass , thrombus vegetation . 11 . Patients actively participate another drug device investigational study yet complete primary endpoint followup period . 12 . Patients suffer dementia . 13 . Pregnant nursing woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>TAVI</keyword>
	<keyword>trans-femoral</keyword>
	<keyword>Sapien</keyword>
	<keyword>Lotus</keyword>
</DOC>